Allarity Therapeutics (ALLR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ALLR Allarity Therapeutics

Watchlist

0.9901
-0.0399-3.87%

Close Dec 20 16:00 ET

1.0097
+0.0196+1.98%

Post 20:01 ET

4.39MMarket Cap-0.14P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Allarity Therapeutics Inc - Two Patients Exceed 14 Months on Treatment in Phase 2 Trial
ReutersNov 18 08:00 ET
Express News | Allarity Therapeutics Inc - Maintains Cash Balance of $18.5 Million
ReutersNov 18 08:00 ET
Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
GlobeNewswireNov 18 08:00 ET
Allarity Therapeutics | 10-Q: Q3 2024 Earnings Report
SECNov 14 16:25 ET · Announcements
Express News | Allarity Therapeutics Q3 EPS $(7.71) Beats $(8.40) Estimate
BenzingaNov 14 08:28 ET
Allarity Therapeutics | 8-K: Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights
SECNov 14 08:21 ET

Comments

Stock_Drift

Yesterday 00:24

Low Floats. 11:22am

$Evoke Pharma (EVOK.US)$ $Mainz Biomed (MYNZ.US)$ $Allarity Therapeutics (ALLR.US)$ $NLS Pharmaceutics (NLSP.US)$ $Gelteq (GELS.US)$ $Real Messenger (RMSG.US)$ $Elevai Labs (ELAB.US)$ $DallasNews (DALN.US)$ $Avalon GloboCare (ALBT.US)$ $Psyence Biomedical (PBM.US)$ $XChange TEC (XHG.US)$ $Trio Petroleum (TPET.US)$ $PainReform (PRFX.US)$
📊⚡️📊

This_Guy

Dec 19 09:54

$Allarity Therapeutics (ALLR.US)$
👀

Shroomie

Dec 17 14:43

shorts covering or potential pump after hours 🤔

$Allarity Therapeutics (ALLR.US)$

Shroomie

Nov 27 15:39

look at all these bagholders in the 5 dollar range... amazing

$Allarity Therapeutics (ALLR.US)$

Jaguar8

Nov 18 09:48

NEWS PM

$Allarity Therapeutics (ALLR.US)$
Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Allarity Therapeutics (NASDAQ: ALLR) reported significant progress in its Phase 2 stenoparib trial for advanced ovarian cancer, with two patients exceeding 14 months of treatment.
The company maintains a strong financial position with $18.5 million cash balance as of September 30, 2024, enabling advancement toward FDA approval. Additionally, Allarit...

Heat List

Overall

No Data